BR112018010692A2 - composições imunoestimuladoras, usos de melanina ou de um precursor da melanina e método para obter uma composição imunoestimuladora - Google Patents

composições imunoestimuladoras, usos de melanina ou de um precursor da melanina e método para obter uma composição imunoestimuladora

Info

Publication number
BR112018010692A2
BR112018010692A2 BR112018010692A BR112018010692A BR112018010692A2 BR 112018010692 A2 BR112018010692 A2 BR 112018010692A2 BR 112018010692 A BR112018010692 A BR 112018010692A BR 112018010692 A BR112018010692 A BR 112018010692A BR 112018010692 A2 BR112018010692 A2 BR 112018010692A2
Authority
BR
Brazil
Prior art keywords
melanin
immunostimulatory
obtaining
compositions
precursor
Prior art date
Application number
BR112018010692A
Other languages
English (en)
Other versions
BR112018010692A8 (pt
Inventor
Carpentier Antoine
Banissi Claire
Original Assignee
Hopitaux Paris Assist Publique
Univ Paris 13
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hopitaux Paris Assist Publique, Univ Paris 13 filed Critical Hopitaux Paris Assist Publique
Publication of BR112018010692A2 publication Critical patent/BR112018010692A2/pt
Publication of BR112018010692A8 publication Critical patent/BR112018010692A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/572—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 cytotoxic response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6093—Synthetic polymers, e.g. polyethyleneglycol [PEG], Polymers or copolymers of (D) glutamate and (D) lysine

Abstract

a invenção diz respeito ao uso da melanina, complexada com um antígeno, como uma composição imunoestimuladora.
BR112018010692A 2015-11-27 2016-11-25 composições imunoestimuladoras, usos de melanina ou de um precursor da melanina e método para obter uma composição imunoestimuladora BR112018010692A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15306887.9A EP3173098A1 (en) 2015-11-27 2015-11-27 Immunostimulatory compositions
PCT/EP2016/078794 WO2017089529A1 (en) 2015-11-27 2016-11-25 Immunostimulatory compositions

Publications (2)

Publication Number Publication Date
BR112018010692A2 true BR112018010692A2 (pt) 2018-11-13
BR112018010692A8 BR112018010692A8 (pt) 2019-02-26

Family

ID=55024030

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018010692A BR112018010692A8 (pt) 2015-11-27 2016-11-25 composições imunoestimuladoras, usos de melanina ou de um precursor da melanina e método para obter uma composição imunoestimuladora

Country Status (19)

Country Link
US (2) US10857227B2 (pt)
EP (2) EP3173098A1 (pt)
JP (1) JP7033539B2 (pt)
KR (1) KR102448132B1 (pt)
CN (1) CN108601826B (pt)
AU (1) AU2016360902B2 (pt)
BR (1) BR112018010692A8 (pt)
CA (1) CA3005930C (pt)
DK (1) DK3380120T3 (pt)
ES (1) ES2877552T3 (pt)
HR (1) HRP20211085T1 (pt)
HU (1) HUE055517T2 (pt)
IL (1) IL259575B (pt)
LT (1) LT3380120T (pt)
PL (1) PL3380120T3 (pt)
PT (1) PT3380120T (pt)
RU (1) RU2732118C2 (pt)
SI (1) SI3380120T1 (pt)
WO (1) WO2017089529A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3173098A1 (en) * 2015-11-27 2017-05-31 Assistance Publique-Hopitaux De Paris Immunostimulatory compositions
WO2019084259A1 (en) * 2017-10-25 2019-05-02 North Carolina State University DERMAL APPLICATOR FOR USE IN ANTICANCER PHOTO IMMUNOTHERAPY
EP3868401A1 (en) 2020-02-21 2021-08-25 Assistance Publique Hôpitaux de Paris Optimization of peptide-melanin binding
CN112826928A (zh) * 2020-11-20 2021-05-25 郑州大学 一种cd40靶向树突状细胞纳米疫苗及其构建方法
CN115969974A (zh) * 2022-12-29 2023-04-18 重庆医科大学附属第二医院 一种异黑素类仿生纳米粒和制备方法及其在原位胶质母细胞瘤光热免疫治疗中的应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL62091A0 (en) 1981-02-09 1981-03-31 Furman V Installation for the transportation of bulk material between a shore and an offshore marine vessel
US4855144A (en) 1987-10-23 1989-08-08 Advanced Polymer Systems Synthetic melanin aggregates
US5210076A (en) 1988-09-13 1993-05-11 Berliner David L Methods of treating Parkinson's disease using melanin
LU87672A1 (fr) 1990-02-05 1991-10-08 Oreal Procede de preparation d'un pigment melanique par voie enzymatique
US5227459A (en) 1990-05-18 1993-07-13 Yale University Synthetic melanin
US5225435A (en) 1990-05-18 1993-07-06 Yale University Soluble melanin
EP0637955A4 (en) 1992-04-29 1995-11-08 Bristol Myers Squibb Co HAIR COLORING COMPOSITION OF 5,6-DIHYDROXYINDOL AND AN OXIDIZING AGENT BASED ON CHLORITE AND RELEVANT DYEING PROCESS.
GB9215354D0 (en) 1992-07-20 1992-09-02 Unilever Plc Cosmetic composition
AU7958394A (en) 1993-10-01 1995-05-01 Yale University Synthetic melanin
US6080409A (en) 1995-12-28 2000-06-27 Dendreon Corporation Immunostimulatory method
US5792220A (en) 1997-05-16 1998-08-11 Bristol-Myers Squibb Company Dyeing hair with melanin procursors in the presence of iodate and peroxide
SK284664B6 (sk) 1998-08-13 2005-08-04 Ing. Csc. Kereste� J�N Biologicky účinná frakcia rastlinného melanínu, spôsob jej výroby, farmaceutický prostriedok s jej obsahom a jej použitie
WO2000040262A1 (en) 1999-01-05 2000-07-13 The Flinders University Of South Australia Novel agents and methods for treatment and diagnosis of ocular disorders
US20040057958A1 (en) * 2002-05-17 2004-03-25 Waggoner David W. Immunogenicity-enhancing carriers and compositions thereof and methods of using the same
US7846452B2 (en) 2004-07-30 2010-12-07 The University Of Mississippi Potent immunostimulatory extracts from microalgae
US20090142362A1 (en) * 2006-11-06 2009-06-04 Avant Immunotherapeutics, Inc. Peptide-based vaccine compositions to endogenous cholesteryl ester transfer protein (CETP)
US8784895B2 (en) * 2011-03-15 2014-07-22 Northwestern University Multifunctional metal nanoparticles having a polydopamine-based surface and methods of making and using the same
US9408882B2 (en) 2011-03-18 2016-08-09 Albert Einstein College Of Medicine, Inc. Oral administration of melanin for protection against radiation
EP3173098A1 (en) * 2015-11-27 2017-05-31 Assistance Publique-Hopitaux De Paris Immunostimulatory compositions

Also Published As

Publication number Publication date
AU2016360902B2 (en) 2023-03-09
RU2018123170A (ru) 2019-12-27
RU2732118C2 (ru) 2020-09-11
IL259575B (en) 2021-07-29
EP3173098A1 (en) 2017-05-31
SI3380120T1 (sl) 2021-11-30
US10857227B2 (en) 2020-12-08
LT3380120T (lt) 2021-08-10
DK3380120T3 (da) 2021-07-12
EP3380120A1 (en) 2018-10-03
US20210060156A1 (en) 2021-03-04
PL3380120T3 (pl) 2021-12-13
EP3380120B1 (en) 2021-04-21
CA3005930C (en) 2022-11-01
ES2877552T3 (es) 2021-11-17
BR112018010692A8 (pt) 2019-02-26
PT3380120T (pt) 2021-06-24
US11904014B2 (en) 2024-02-20
HUE055517T2 (hu) 2021-12-28
JP7033539B2 (ja) 2022-03-10
CN108601826B (zh) 2021-10-26
JP2018535271A (ja) 2018-11-29
US20180333483A1 (en) 2018-11-22
CN108601826A (zh) 2018-09-28
CA3005930A1 (en) 2017-06-01
KR102448132B1 (ko) 2022-09-27
KR20180082593A (ko) 2018-07-18
HRP20211085T1 (hr) 2021-10-01
RU2018123170A3 (pt) 2020-03-04
WO2017089529A1 (en) 2017-06-01
IL259575A (en) 2018-07-31
AU2016360902A1 (en) 2018-06-21

Similar Documents

Publication Publication Date Title
MX2023008693A (es) Polinucleotidos moduladores.
MX2018014154A (es) Polinucleotidos moduladores.
MX2019003735A (es) Formulaciones diluibles de cannabinoides y procesos para su preparacion.
CL2016003398A1 (es) Compuestos de heteroarilo útiles como inhibidores de enzima activadora de sumo.
BR112017009497A2 (pt) polinucleotídeos de aadc para o tratamento da doença de parkinson
BR112016024644A2 (pt) vacinas de ácido nucleico
BR112018010692A2 (pt) composições imunoestimuladoras, usos de melanina ou de um precursor da melanina e método para obter uma composição imunoestimuladora
BR112017023567A2 (pt) celulose nanofibrilar, método para a fabricação de celulose nanofibrilar, membrana, uso de celulose nanofibrilar, e, produto.
CL2019002251A1 (es) Anticuerpos contra triptasa, composiciones de estos y usos de estos.
BR112016020618A2 (pt) oligômero antissentido, composição farmacêutica, e, uso de um oligômero antissentido
BR112017009374A2 (pt) ?composições de ramnolipídeo de baixa viscosidade concentradas?
PH12019501359A1 (en) Polymorphs
BR112017012210A2 (pt) solução conservante de célula, uso da mesma e método de produção de solução conservante de célula
BR112018005749A2 (pt) composições para higiene bucal e métodos de uso
DK3513809T3 (da) Medicinsk sammensætning, som omfatter tivozanib
MX2019002057A (es) Formas solidas de mesilato de cenicriviroc y procesos para elaborar formas sólidas de mesilato de cenicriviroc.
BR112018003864A2 (pt) método para preparação de uma composição de ácido hialurônico, composição, e, método para restauração de um tecido
BR112017025711A2 (pt) ?composições, processo para preparação de siloxanos modificados por poliéter e uso das composições inovadoras?
BR112018012313A2 (pt) composições que compreendem 15-hepe e métodos para uso das mesmas
MX2018005784A (es) Mezcla hemostatica de fibras cortas y largas basadas en celulosa.
MX2017008390A (es) Uretanos funcionalizados con alcoxisilano y funcionalizados con alofanato.
BR112016024096A2 (pt) novo bacteriófago e composição compreendendo o mesmo
DOP2016000073A (es) Composiciones y métodos para inhibir la expresión del gen alas1
BR112015032526A2 (pt) composições anticaspa e métodos de uso das mesmas
BR112017020896A2 (pt) variantes de protoxina-ii e métodos de uso

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]